SPRB stock results show that Spruce Biosciences beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. More
Articles
CARA Stock Earnings: Cara Therapeutics Misses EPS, Beats Revenue for Q1 2024
CARA stock results show that Cara Therapeutics missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. More
DERM Stock Earnings: Journey Medical Beats EPS, Misses Revenue for Q1 2024
DERM stock results show that Journey Medical beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. More
HROW Stock Earnings: Harrow Health Misses EPS, Misses Revenue for Q1 2024
HROW stock results show that Harrow Health missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. More
TKNO Stock Earnings: Alpha Teknova Beats EPS, Beats Revenue for Q1 2024
TKNO stock results show that Alpha Teknova beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. More
ALLO Stock Earnings: Allogene Therapeutics Beats EPS, Beats Revenue for Q1 2024
ALLO stock results show that Allogene Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. More
AUGX Stock Earnings: Augmedix Beats EPS, Beats Revenue for Q1 2024
AUGX stock results show that Augmedix beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. More
